Efficacy and safety of Naga Bhasma and Nisha-Amalaki Churna in the management of Madhumeha (type 2 diabetes) - A double-blind, randomized, controlled clinical trial

Author:

Krushnakumar Taviad1,Sarika Makwana23,Prashant Bedarkar23,Patgiri BJ23

Affiliation:

1. Medical Officer, Government Ayurved Dispensary Pingali, Panchmahal, Gujarat, India

2. Department of Rasa Shastra and Bhaisajya Kalpana, ITRA, Jamnagar, Gujarat, India

3. Jamnagar, Gujarat, India

Abstract

Abstract Background: Increasing global incidence of diabetes is a serious issue and large number of researches are undergoing to find promising cure of this chronic disease. Many Ayurveda drugs have been evaluated for anti-diabetic properties; however, researches on metallic/mineral based drugs are very few. The present study aimed to assess the comparative efficacy and safety of Shashti Puta Naga Bhasma (SNB) - Trimshati Puta Naga Bhasma (TNB) with Nisha-Amalaki Churna (NAC), NAC and metformin in the management of type 2 diabetes. Materials and methods: In this prospective, randomized, double blind, active controlled study; 132 patients with type 2 diabetes were included and randomly divided into four groups. Patients were treated with NAC (125 mg) with placebo (roasted Sooji; course powder of wheat flour), SNB (62.5 mg) with NAC (125 mg), TNB (62.5 mg) with NAC (125 mg) twice daily before food with honey while patients in last group were continued with their ongoing Tablet Metformin 500 mg prescribed by physician as standard control without any other additional intervention for 90 days. The assessment of changes observed in blood glucose, glycosylated hemoglobin, lipid profile, hemogram, hepatic, renal profile, and clinical symptoms was carried out. Results: After 90 days of medication, fasting and postprandial blood glucose levels and clinical symptoms in three groups were significantly decreased when compared with baseline except NAC group. Hemogram and hepatic and renal profiles (safety parameters) in the four groups were not significantly different from the baseline. No adverse events were reported with the use of the studied medicine. Conclusion: SNB along with NAC possessed more symptomatic relief in comparison to TNB with NAC, NAC alone and Metformin thereby improving the quality of life of patients along with significant glycemic control and free from any significant side effects.

Publisher

Medknow

Reference27 articles.

1. World diabetes day 2018:Battling the emerging epidemic of diabetic retinopathy;Suresh;Indian J Ophthalmol,2018

2. Alternative therapies for type 2 diabetes;Lucy;Altern Med Rev,2002

3. Efficacy of Ayurvedic remedies in type 2 diabetes:A review through works done at Gujarat Ayurveda University, Jamnagar;Sharma;J Med Nutr Nutraceutical,2015

4. Screening of antidiabetic effect of Naga Bhasma in alloxan induced hyperglycemic rats;Deshmukh;Int J Res Ayurveda Pharm,2013

5. Experimental study on anti-hyperglycemic effect of Naga Bhasma (incinerated lead);Rajput;J Indian Syst Med,2015

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3